FISH, Plasma Cell Myeloma (PCM) Panel
GTR Test Accession: Help GTR000569815.1
CAP
IMMUNOLOGYINHERITED DISEASECANCER ... View more
Last updated in GTR: 2019-12-30
Last annual review date for the lab: 2024-01-10 LinkOut
At a Glance
Diagnosis; Prognostic
Multiple myeloma
Chromosome 11q23.3; Chromosome 13q14.3; Chromosome 14q32.3; Chromosome 17p13; Chromosome 1q21; ...
Cytogenetics - FISH-interphase: Fluorescence in situ hybridization (FISH)
Plasma cell neoplasms
Not provided
Not provided
Ordering Information
Offered by: Help
IU Genetic Testing Laboratories
View lab's website
View lab's test page
Specimen Source: Help
Who can order: Help
  • Genetic Counselor
  • Health Care Provider
  • Licensed Physician
  • Nurse Practitioner
Lab contact: Help
Lisa Wright, MS, CG(ASCP), Laboratory Manager
llwright@iu.edu
317-274-5219
Contact Policy: Help
Laboratory can only accept contact from health care providers. Patients/families are encouraged to discuss genetic testing options with their health care provider.
How to Order: Help
Test development: Help
Test developed by laboratory (no manufacturer test name)
Informed consent required: Help
Decline to answer
Pre-test genetic counseling required: Help
Decline to answer
Post-test genetic counseling required: Help
Decline to answer
Recommended fields not provided:
Conditions Help
Total conditions: 1
Condition/Phenotype Identifier
Test Targets
Chromosomal regions/Mitochondria Help
Total chromosomal regions/mitochondria: 9
Chromosomal region/Mitochondrion Associated condition
Methodology
Total methods: 1
Method Category Help
Test method Help
Instrument *
FISH-interphase
Fluorescence in situ hybridization (FISH)
* Instrument: Not provided
Clinical Information
Test purpose: Help
Diagnosis; Prognostic
Target population: Help
Plasma cell neoplasms
Recommended fields not provided:
Technical Information
Availability: Help
Tests performed
Entire test performed in-house
Analytical Validity: Help
This test was developed and its performance characteristics determined by the IU Cytogenetics Laboratory as required by CLIA '88 regulations. It has not been cleared or approved by the U.S. Food & Drug Administration. Additional information about testing parameters including reporting criteria is available upon request.
Proficiency testing (PT):
Is proficiency testing performed for this test? Help
Yes

Method used for proficiency testing: Help
Formal PT program

PT Provider: Help
American College of Medical Genetics / College of American Pathologists, ACMG/CAP
Recommended fields not provided:
Regulatory Approval
FDA Review: Help
Not provided
Additional Information

IMPORTANT NOTE: NIH does not independently verify information submitted to GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.